PATIENCE IVIE IHEJIRIKA, Abuja Nigeria has received about four million doses of the 16 million Oxford-AstraZeneca vaccine approved to fight COVID-19, via the COVAX arrangement. COVAX is short for COVID-19 Vaccines Global Access. Yet, recent suspension of AstraZeneca vaccine in some countries, including South Africa and Ireland, over concerns of effectiveness and safety has heightened […]
Source: Leadership Newspaper
